Source: Public Filings
ENTITY
Abbisko Cayman (2256 HK)
Abbisko Cayman (2256 HK)
18
Analysis
Health Care • China
Abbisko Cayman Limited operates as a biopharmaceutical company. The Company dedicated to the discovery and development of innovative and differentiated small molecule incology therapies. Abbisko Cayman provides services in China.
more
x